Feasibility Trial Testing the Bionic Pancreas With ZP4207

NCT02971228 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Insulin Lispro
DRUG: ZP4207 (dasiglucagon)
DRUG: Glucagon
DEVICE: iPhone-based bionic pancreas
DEVICE: iLet-based bionic pancreas

Sponsor

Zealand Pharma

Collaborators

[object Object]
[object Object]